Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The RNA Sequencing Services Market Today And What Is Its Future Size?
In recent years, the RNA sequencing services market has experienced significant growth. It’s expected to rise from $3.58 billion in 2024 to $3.99 billion in 2025, with an annual compound growth rate of 11.4%. The previously seen growth in this sector can be linked to a greater interest in personalized medicine, improvements in bioinformatics tools, an increased emphasis on drug discovery and development, augmented utilization of RNA sequencing in agricultural studies, and a broader application in clinical diagnostics.
In the coming years, the rna sequencing services market size is predicted to experience a rapid expansion. By 2029, it’s predicted to reach a value of $5.92 billion, growing at a compound annual growth rate (CAGR) of 10.4%. Factors such as the development of single-cell RNA sequencing technologies, incorporation of artificial intelligence and machine learning into data interpretation, expanding research into non-coding RNA biomarkers, increasing demand for transcriptomic analysis in the field of immunotherapy research, and strengthening collaborations between academic and industrial entities for genomic studies are the key drivers of growth during the forecast period. A shift towards adopting long-read sequencing, deploying cloud-based platforms for analysis, escalating demand for RNA splicing analysis, and integrating multi-omics data are expected to be major trends throughout the forecast period.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp
What External And Internal Drivers Are Influencing The RNA Sequencing Services Market?
The RNA sequencing services market is experiencing significant expansion due to the rising need for personalized medicine. Personalized medicine encompasses customizing medical care based on individual traits, including genetics and lifestyle, enhancing the drug’s efficacy while minimizing side effects. The increasing interest in personalized medicine stems from its capability to offer more efficient treatments, advances in genomics, escalating complexity of diseases, and advantageous regulatory support. RNA sequencing services facilitate disease subtype identification, biomarker discovery, therapeutic target recognition, therapy response prediction, and monitoring of disease progression and treatment outcomes. Personalized medicine methodologies employ RNA sequencing technologies to develop individualized and effective drugs that target distinct molecular traits of individual patients. For instance, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, revealed that the FDA (Food and Drug Administration) gave the green light to 16 innovative personalized therapies for patients with rare diseases in 2023, in contrast to six in 2022. The freshly approved personalized treatments for 2023 also consist of seven drugs for cancer and three other diseases and conditions. Consequently, the surging demand for personalized medicine is propelling the growth of the RNA sequencing services market in the future.
How Is The RNA Sequencing Services Market Categorized Across Applications And Types?
The rna sequencing servicesmarket covered in this report is segmented –
1) By Type: Ribosomal RNA (rRNA); Transfer RNA (tRNA); Long non-coding RNA (lncRNA)
2) By Sequencing Method: Next Generation Sequencing Methods; Other Sequencing Methods
3) By Application Area: Research Purposes; Diagnostic Purposes
4) By End Users: Academic And Government Institutes And Research Centers; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
Subsegments:
1) By Ribosomal RNA (rRNA): Total RRNA Sequencing; RRNA Depletion
2) By Transfer RNA (tRNA): TRNA Profiling; TRNA Sequencing
3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling; lncRNA Sequencing
How Are Industry Trends Steering The Expansion Of The RNA Sequencing Services Market?
Leading businesses in the RNA sequencing services market, like the next-generation sequencing (NGS) assay, are embracing automation to minimize human errors and increase the effectiveness and precision of data creation and examination. The RNA next-generation sequencing (RNA-seq) assay is a potent tool employed in molecular biology and genomics for decoding the transcriptome of a biological specimen. Tempus, a precision medicine technology business in the United States, launched its standalone RNA next-generation sequencing assay titled Tempus xR in June 2023. This groundbreaking assay, intended for solid tumors, delivers an all-encompassing analysis of the entirety of the transcriptome, showcasing significant fusions in more than 100 targeted genes besides altered splicing for the MET Exon 14 and EGFRvIII. Acknowledging the importance of RNA sequencing data, Tempus has traditionally incorporated RNA and DNA sequencing into its standard xT broad-panel assay. Now, customers can choose to order each test individually or concurrently, with the chance to add specific Tempus algorithmic tests to xR. This offering is geared toward doctors concentrating on RNA fusions or altered splicing, and also suppliers, investigators, and biopharma companies looking for thorough RNA sequencing examination of their current samples.
Who Are The Global Leaders Steering The RNA Sequencing Services Market Forward?
Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report
What Are The Emerging Regional Trends Driving The RNA Sequencing Services Market?
North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp
Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2025, By The Business Research Company
Antisense And Rnai Therapeutics Global Market Report 2025
Rna Analysis Transcriptomics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Ngs Based Rna Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
